Belharra Therapeutics
- Website
- belharratx.com
- Total Funding
- $50.0M
- Last Round
- $50.0M Series AJan 2023
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Belharra Therapeutics is an Advanced Materials company. It has raised $50.0M in total across 1 round, most recently a $50.0M Series A round in Jan 2023. Investors include Versant Ventures.
Funding History
Jan 2023
Investors
Similar Companies

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/belharra-therapeutics"><img src="https://indexed.vc/api/badge/company/belharra-therapeutics" alt="Belharra Therapeutics on Indexed.vc" width="260" height="76" /></a>